Acute coronary syndrome Optical coherence tomography (OCT) - PowerPoint PPT Presentation

Aug 18, 2023 •284 likes •449 views

Acute coronary syndrome Optical coherence tomography (OCT) Rationale Aim of the study Healthy wall profile Segmentation problem Dynamic programming Machine Learning Study protocol Segmentation results Classification results Classification

Acute coronary syndrome
Optical coherence tomography (OCT)
Rationale
Aim of the study
Healthy wall profile
Segmentation problem
Dynamic programming
Machine Learning
Study protocol
Segmentation results
Classification results
Classification errors
Full pullback summary
Your logos here Contour segmentation of the intima, media and adventitia layers in intracoronary OCT images Application to fully-automatic detection of healthy wall regions Guillaume Zahnd, Ayla Hoogendoorn, Nicolas Combaret, Antonios Karanasos, Emilie Pery, Laurent Sarry, Pascal Motref, TITEL Wiro Niessen, Evelyn Regar, Gijs van Soest, Theo van Walsum Author

Recommend

Intravascular Megahertz Doppler Optical Coherence Tomography Tianshi Wang Phase-sensitive

Intravascular Megahertz Doppler Optical Coherence Tomography Tianshi Wang Phase-sensitive Optical coherence tomography FFT Absolute signal a + bi Coherence fringes Phase signal OCT image of coronary artery Velocity = d / t Sensitive

308 views • 20 slides

ACUTE CORONARY SYNDROME DR CHEVAAN HENDRICKSE INTERVENTIONAL CARDIOLOGIST Conflicts of interest

ACUTE CORONARY SYNDROME DR CHEVAAN HENDRICKSE INTERVENTIONAL CARDIOLOGIST Conflicts of interest None ACUTE CORONARY SYNDROMES CHRONIC CORONARY SYNDROMES (2019) CASE STUDY 50 YEAR OLD Risk factors : Hypertension, Smoker Central,

1.21k views • 82 slides

Acute coronary syndrome in a postpartum patient with Hellp Syndrome E G. Laws 1 , M. Mariani 1 ,

Acute coronary syndrome in a postpartum patient with Hellp Syndrome E G. Laws 1 , M. Mariani 1 , U. Paradossi 1 , R. Marrai 2, G. Casilla 2 , C. Angiolini 2, S. Baldassari 1 , S. Luciani 1 , J. Giannetti 1 , S. Baratta 1 (1) Gabriele Monasterio

431 views • 16 slides

Clinical Assessment of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary

Clinical Assessment of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Prasugrel or Clopidogrel using Academic Center Databases - The PROMETHEUS Study- Study Organization Data

335 views • 22 slides

Acute Coronary syndrome 7th Annual Pharmacotherapy Conference ACS Pathophysiology rupture or

6/2/18 Acute Coronary syndrome 7th Annual Pharmacotherapy Conference ACS Pathophysiology rupture or erosion of a vulnerable, lipid- laden, atherosclerotic coronary plaque, resulting in exposure of circulating blood to highly thrombogenic

407 views • 17 slides

Acute Coronary Syndrome Dr. Annie Sun What is ACS? unstable angina non- ST elevation MI

Acute Coronary Syndrome Dr. Annie Sun What is ACS? unstable angina non- ST elevation MI (NSTEMI) ST elevation MI (STEMI) ACS/ STEMI Review 90% of acute MIs caused by thrombus formation from rupture of unstable plaques 3 Coronary

828 views • 70 slides

Ticagrelor versus Clopidogrel in Troponin- negative Patients with Acute Coronary Syndrome

Ticagrelor versus Clopidogrel in Troponin- negative Patients with Acute Coronary Syndrome Undergoing Ad-Hoc Percutaneous Coronary Intervention: Results of a Prospective, Randomized, Multicenter Pharmacodynamic Study Roxana Mehran, Dominick J.

1.39k views • 23 slides

COMPLEX PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY INTERVENTION FOR ACUTE CORONARY

COMPLEX PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROME IN A PATIENT WITH THORACIC AORTIC ANEURYSM AFTER STENT GRAFT AORTIC ANEURYSM AFTER STENT GRAFT TREATMENT Zu-Yin Chen, MD; Tao-Cheng Wu, MD

467 views • 17 slides

Optical Coherence Tomography Incorporating Spatial priors Da Ma 1* , Donghuan Lu 1,2* , Morgan

Cascade Dual-branch Deep Neural Networks for Retinal Layer and fluid Segmentation of Optical Coherence Tomography Incorporating Spatial priors Da Ma 1* , Donghuan Lu 1,2* , Morgan Heisler 1 , Setareh Dabiri 1 , Sieun Lee 1 , Gavin Weiguang Ding 1 ,

359 views • 8 slides

10/22/16 Lay of the land Update on Acute Coronary Syndrome: Case studies with an emphasis on

10/22/16 Lay of the land Update on Acute Coronary Syndrome: Case studies with an emphasis on discussions Five Things Hospitalists Must Know Focus on five key take-home points Grounded in evidence, not acronyms Dhruv S. Kazi, MD, MSc, MS

430 views • 12 slides

with Varespladib and Cardiovascular Events in Patients with an Acute Coronary Syndrome: Results

Secretory Phospholipase A 2 Inhibition with Varespladib and Cardiovascular Events in Patients with an Acute Coronary Syndrome: Results of the VISTA-16 Study SJ Nicholls, JJP Kastelein, GG Schwartz, D Bash and DM Brennan. Disclosures

230 views • 19 slides

Delayed Presentation of Acute Coronary Syndrome: A challenge in its early management in a Click

Delayed Presentation of Acute Coronary Syndrome: A challenge in its early management in a Click to edit Master subtitle style resource poor country Karki P1, Acharya P1, Adhikari RR1, Bhattarai J, 1 Shrestha NR1,Sharma SK1 1Department of

286 views • 26 slides

Optimal antithrombotic treatment after acute coronary syndrome: the (complicated) near future

Optimal antithrombotic treatment after acute coronary syndrome: the (complicated) near future Jur ten Berg Associate Professor, PhD, MSc, FESC, FACC St. Antonius Hospital, Nieuwegein, the Netherlands; University Hospital Groningen, the

516 views • 36 slides

Acute Coronary Syndrome (ELIXA) Eldrin F. Lewis, MD, MPH Associate Professor of Medicine Harvard

ESC 31 August 2015 Hot Line III - Diabetes mellitus/Pharmacology Evaluation of LIXisenatide in Acute Coronary Syndrome (ELIXA) Eldrin F. Lewis, MD, MPH Associate Professor of Medicine Harvard Medical School Brigham and Womens Hospital

479 views • 11 slides

Alirocumab in Patients After Acute Coronary Syndrome Gregory G. Schwartz, Michael Szarek, Deepak

The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome Gregory G. Schwartz, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Diaz, Jay Edelberg, Shaun G. Goodman, Corinne Hanotin, Robert Harrington,

713 views • 55 slides

The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome

623 views • 47 slides

CHANGE DAPT Clopidogrel or ticagrelor in acute coronary syndrome patients treated with

Press Conference 29-08-2017; CHANGE DAPT CHANGE DAPT Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents P. Zocca, L.C. van der Heijden, M.M. Kok, M.M. Lwik, M. Hartmann, M.G.

526 views • 7 slides

coherence tomography system Manuel J. Marques, Sylvain Rivet, Adrian Bradu and Adrian Podoleanu

Polarization-sensitive plug-in optical module for a Fourier-domain optical coherence tomography system Manuel J. Marques, Sylvain Rivet, Adrian Bradu and Adrian Podoleanu Applied Optics Group, School of Physical Sciences, University of Kent,

267 views • 14 slides

Clinical Presentation and Outcome of Acute Coronary Syndrome in a Tertiary Hospital in Jeddah, KSA

JKAU: Med. Sci., Vol. 14 No. 4, pp: 61-70 (2007 A.D. / 1428 A.H.) Clinical Presentation and Outcome of Acute Coronary Syndrome in a Tertiary Hospital in Jeddah, KSA Aisha M. Siddiqui, FRCP ( E DIN ) Department of Medicine, Faculty of Medicine

111 views • 10 slides

monitoring multiple sclerosis Dra. Celia Oreja-Guevara Multiple Sclerosis Unit Head of Clinical

Optical coherence tomography: A role in monitoring multiple sclerosis Dra. Celia Oreja-Guevara Multiple Sclerosis Unit Head of Clinical Research Hospital Clnico San Carlos, Madrid Spain London , 17.10.2013 Optical coherence tomography

765 views • 30 slides

Improving Care Processes for Patients with Possible Acute Coronary Syndrome ( ICARE-ACS )

Improving Care Processes for Patients with Possible Acute Coronary Syndrome ( ICARE-ACS ) Patients with p potential A ACS CS ACS 20% Non-ACS 80% 0 2 4 6 ED 8 Ward 10 12+ Time MT 22.09.14 Patients w with p potential A ACS ACS

709 views • 28 slides

Ruby 1 Safety, Tolerability and Efficacy of Darexaban (YM150) in Patients with Acute Coronary

Ruby 1 Safety, Tolerability and Efficacy of Darexaban (YM150) in Patients with Acute Coronary Syndrome: a Phase II Study Ph Gabriel Steg , J Wouter Jukema, Gregory YH Lip, Shamir R Mehta, Ronny W Renfurm, Christopher B Granger, on behalf of the

538 views • 30 slides

Early high-dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary

Early high-dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome The PRATO-ACS (Protective effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in

594 views • 22 slides

Heart Institute of Japan apan-PR PRoper level of lipid lOwering with Pitavastatin and Ezetimibe

Heart Institute of Japan apan-PR PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute co coRonary syndrome LDL cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidemia:

122 views • 8 slides